265 related articles for article (PubMed ID: 14630909)
1. Expression of functional Schistosoma mansoni Smad4: role in Erk-mediated transforming growth factor beta (TGF-beta) down-regulation.
Osman A; Niles EG; LoVerde PT
J Biol Chem; 2004 Feb; 279(8):6474-86. PubMed ID: 14630909
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of a Smad2 homologue from Schistosoma mansoni, a transforming growth factor-beta signal transducer.
Osman A; Niles EG; LoVerde PT
J Biol Chem; 2001 Mar; 276(13):10072-82. PubMed ID: 11152451
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of an R-Smad ortholog (SmSmad1B) from Schistosoma mansoni.
Carlo JM; Osman A; Niles EG; Wu W; Fantappie MR; Oliveira FM; LoVerde PT
FEBS J; 2007 Aug; 274(16):4075-93. PubMed ID: 17635586
[TBL] [Abstract][Full Text] [Related]
4. Functional conservation of Schistosoma mansoni Smads in TGF-beta signaling.
Beall MJ; McGonigle S; Pearce EJ
Mol Biochem Parasitol; 2000 Nov; 111(1):131-42. PubMed ID: 11087923
[TBL] [Abstract][Full Text] [Related]
5. Schistosoma mansoni TGF-beta receptor II: role in host ligand-induced regulation of a schistosome target gene.
Osman A; Niles EG; Verjovski-Almeida S; LoVerde PT
PLoS Pathog; 2006 Jun; 2(6):e54. PubMed ID: 16789838
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of Smad4 results in resistance against the growth-inhibitory effect of transforming growth factor-beta in the SiHa human cervical carcinoma cell line.
Lee S; Cho YS; Shim C; Kim J; Choi J; Oh S; Kim J; Zhang W; Lee J
Int J Cancer; 2001 Nov; 94(4):500-7. PubMed ID: 11745435
[TBL] [Abstract][Full Text] [Related]
7. Eukaryotic initiation factor 2 alpha subunit associates with TGF beta receptors and 14-3-3 epsilon and acts as a modulator of the TGF beta response.
McGonigle S; Beall MJ; Pearce EJ
Biochemistry; 2002 Jan; 41(2):579-87. PubMed ID: 11781097
[TBL] [Abstract][Full Text] [Related]
8. Sumoylation of Smad4, the common Smad mediator of transforming growth factor-beta family signaling.
Lee PS; Chang C; Liu D; Derynck R
J Biol Chem; 2003 Jul; 278(30):27853-63. PubMed ID: 12740389
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of smad-transforming growth factor beta signaling by Ca(2+)-calmodulin-dependent protein kinase II.
Wicks SJ; Lui S; Abdel-Wahab N; Mason RM; Chantry A
Mol Cell Biol; 2000 Nov; 20(21):8103-11. PubMed ID: 11027280
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells.
Watanabe H; de Caestecker MP; Yamada Y
J Biol Chem; 2001 Apr; 276(17):14466-73. PubMed ID: 11278290
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterisation of a second structurally unusual AR-Smad without an MH1 domain and a Smad4 orthologue from Echinococcus multilocularis.
Zavala-Góngora R; Derrer B; Gelmedin V; Knaus P; Brehm K
Int J Parasitol; 2008 Feb; 38(2):161-76. PubMed ID: 17845804
[TBL] [Abstract][Full Text] [Related]
12. Functional cloning of the proto-oncogene brain factor-1 (BF-1) as a Smad-binding antagonist of transforming growth factor-beta signaling.
Rodriguez C; Huang LJ; Son JK; McKee A; Xiao Z; Lodish HF
J Biol Chem; 2001 Aug; 276(32):30224-30. PubMed ID: 11387330
[TBL] [Abstract][Full Text] [Related]
13. Tumor-derived C-terminal mutations of Smad4 with decreased DNA binding activity and enhanced intramolecular interaction.
Kuang C; Chen Y
Oncogene; 2004 Feb; 23(5):1021-9. PubMed ID: 14647410
[TBL] [Abstract][Full Text] [Related]
14. Nuclear factor YY1 inhibits transforming growth factor beta- and bone morphogenetic protein-induced cell differentiation.
Kurisaki K; Kurisaki A; Valcourt U; Terentiev AA; Pardali K; Ten Dijke P; Heldin CH; Ericsson J; Moustakas A
Mol Cell Biol; 2003 Jul; 23(13):4494-510. PubMed ID: 12808092
[TBL] [Abstract][Full Text] [Related]
15. Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases.
Morén A; Imamura T; Miyazono K; Heldin CH; Moustakas A
J Biol Chem; 2005 Jun; 280(23):22115-23. PubMed ID: 15817471
[TBL] [Abstract][Full Text] [Related]
16. Human transforming growth factor-beta activates a receptor serine/threonine kinase from the intravascular parasite Schistosoma mansoni.
Beall MJ; Pearce EJ
J Biol Chem; 2001 Aug; 276(34):31613-9. PubMed ID: 11406634
[TBL] [Abstract][Full Text] [Related]
17. TGF beta-induced focal complex formation in epithelial cells is mediated by activated ERK and JNK MAP kinases and is independent of Smad4.
Imamichi Y; Waidmann O; Hein R; Eleftheriou P; Giehl K; Menke A
Biol Chem; 2005 Mar; 386(3):225-36. PubMed ID: 15843168
[TBL] [Abstract][Full Text] [Related]
18. Modeling and analysis of MH1 domain of Smads and their interaction with promoter DNA sequence motif.
Makkar P; Metpally RP; Sangadala S; Reddy BV
J Mol Graph Model; 2009 Apr; 27(7):803-12. PubMed ID: 19157940
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta receptor-associated protein 1 is a Smad4 chaperone.
Wurthner JU; Frank DB; Felici A; Green HM; Cao Z; Schneider MD; McNally JG; Lechleider RJ; Roberts AB
J Biol Chem; 2001 Jun; 276(22):19495-502. PubMed ID: 11278302
[TBL] [Abstract][Full Text] [Related]
20. The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function.
Zhang Y; Musci T; Derynck R
Curr Biol; 1997 Apr; 7(4):270-6. PubMed ID: 9094310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
